Clinical Trial

PurIST Classification-Guided Adaptive Neoadjuvant Chemotherapy by RNA Expression Profiling of EUS Aspiration Samples

Study acronym: PANCREAS
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This is an open-label, phase II study in patients with resectable and borderline resectable pancreatic cancer.
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2020-12-19; most recent amendment 2026-03-03.
Status change: Not Yet Recruiting → Recruiting 2021-08-08
Trial Details
NCT Number NCT04683315
Lead Sponsor Medical College of Wisconsin
Conditions Pancreatic Cancer
Enrollment 84 participants
Start Date 2021-04-01
Primary Completion 2027-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-05